Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ewa Zuba-Surma

Showing results (1-10 of 42) with videos related to

Pageof 5
Sort By:
Cell Transplantation|September 9, 2015
Dimethyl Sulfoxide (DMSO) Increases Percentage of CXCR4(+) Hematopoietic Stem/Progenitor Cells, Their Responsiveness to an SDF-1 Gradient, Homing Capacities, and SurvivalDanuta Jarocha, Ewa Zuba-Surma, Marcin Majka
Acta Biochimica Polonica|December 29, 2019
Impact of developmental origin, niche mechanics and oxygen availability on osteogenic differentiation capacity of mesenchymal stem/stromal cellsNatalia Bryniarska, Andrzej Kubiak, Anna Łabędź-Masłowska, et al.
Polski Merkuriusz Lekarski : Organ Polskiego Towarzystwa Lekarskiego|May 23, 2017
[Role of the bone marrow derived stem cells in pancreatic inflammatory disorders]Krzysztof Dąbkowski, Anna Łabędź-Masłowska, Ewa Zuba-Surma, et al.
Cardiovascular Diabetology|October 30, 2025
Comparison of biological properties of human adipose tissue-derived mesenchymal stem/ stromal cells from healthy and diabetic donors: consequences for cell-based medicinal product developmentPatrycja Dudek, Anna Łabędź-Masłowska, Zbigniew Madeja, et al.
British Journal of Pharmacology|May 24, 2021
Mesenchymal stem cells and extracellular vesicles for the treatment of pain: Current status and perspectivesMarta Bryk, Elżbieta Karnas, Jakub Mlost, et al.
Molecules and Cells|May 3, 2011
CD45-CD14 +CD34 + murine bone marrow low-adherent mesenchymal primitive cells preserve multilineage differentiation potential in long-term in vitro cultureKrzysztof Szade, Ewa Zuba-Surma, Andrzej J Rutkowski, et al.
Cells|August 27, 2021
Processing and Ex Vivo Expansion of Adipose Tissue-Derived Mesenchymal Stem/Stromal Cells for the Development of an Advanced Therapy Medicinal Product for use in HumansAnna Labedz-Maslowska, Agnieszka Szkaradek, Tomasz Mierzwinski, et al.
Oncoimmunology|May 4, 2016
Peripheral trafficking of bone-marrow-derived stem cells in patients with different types of gastric neoplasmsWojciech Błogowski, Ewa Zuba-Surma, Daria Sałata, et al.
Stem Cells International|May 17, 2019
Challenges and Controversies in Human Mesenchymal Stem Cell TherapyBarbara Lukomska, Luiza Stanaszek, Ewa Zuba-Surma, et al.
Anticancer Research|May 31, 2015
Characterization of cells cultured from chylous effusion from a patient with sporadic lymphangioleiomyomatosisIrmina Grzegorek, Ewa Zuba-Surma, Mariusz Chabowski, et al.
Pageof 5

Showing results (1-10 of 42) with videos related to

Sort By:
Pageof 5
Cell Transplantation|September 9, 2015
Dimethyl Sulfoxide (DMSO) Increases Percentage of CXCR4(+) Hematopoietic Stem/Progenitor Cells, Their Responsiveness to an SDF-1 Gradient, Homing Capacities, and SurvivalDanuta Jarocha, Ewa Zuba-Surma, Marcin Majka
Acta Biochimica Polonica|December 29, 2019
Impact of developmental origin, niche mechanics and oxygen availability on osteogenic differentiation capacity of mesenchymal stem/stromal cellsNatalia Bryniarska, Andrzej Kubiak, Anna Łabędź-Masłowska, et al.
Polski Merkuriusz Lekarski : Organ Polskiego Towarzystwa Lekarskiego|May 23, 2017
[Role of the bone marrow derived stem cells in pancreatic inflammatory disorders]Krzysztof Dąbkowski, Anna Łabędź-Masłowska, Ewa Zuba-Surma, et al.
Cardiovascular Diabetology|October 30, 2025
Comparison of biological properties of human adipose tissue-derived mesenchymal stem/ stromal cells from healthy and diabetic donors: consequences for cell-based medicinal product developmentPatrycja Dudek, Anna Łabędź-Masłowska, Zbigniew Madeja, et al.
British Journal of Pharmacology|May 24, 2021
Mesenchymal stem cells and extracellular vesicles for the treatment of pain: Current status and perspectivesMarta Bryk, Elżbieta Karnas, Jakub Mlost, et al.
Molecules and Cells|May 3, 2011
CD45-CD14 +CD34 + murine bone marrow low-adherent mesenchymal primitive cells preserve multilineage differentiation potential in long-term in vitro cultureKrzysztof Szade, Ewa Zuba-Surma, Andrzej J Rutkowski, et al.
Cells|August 27, 2021
Processing and Ex Vivo Expansion of Adipose Tissue-Derived Mesenchymal Stem/Stromal Cells for the Development of an Advanced Therapy Medicinal Product for use in HumansAnna Labedz-Maslowska, Agnieszka Szkaradek, Tomasz Mierzwinski, et al.
Oncoimmunology|May 4, 2016
Peripheral trafficking of bone-marrow-derived stem cells in patients with different types of gastric neoplasmsWojciech Błogowski, Ewa Zuba-Surma, Daria Sałata, et al.
Stem Cells International|May 17, 2019
Challenges and Controversies in Human Mesenchymal Stem Cell TherapyBarbara Lukomska, Luiza Stanaszek, Ewa Zuba-Surma, et al.
Anticancer Research|May 31, 2015
Characterization of cells cultured from chylous effusion from a patient with sporadic lymphangioleiomyomatosisIrmina Grzegorek, Ewa Zuba-Surma, Mariusz Chabowski, et al.
Pageof 5